The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Moran, P. A. P., & Kendall, M. G. (1973) · International Statistical Review / Revue Internationale de Statistique · doi:10.2307/1402637 · Cited by 4,054
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Epidemiologic Research: Principles and Quantitative Methods.
Mayer, L. S., Kleinbaum, D. G., Kupper, L. L., & Morgenstern, H. (1984) · Journal of the American Statistical Association · doi:10.2307/2288427 · Cited by 2,905
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2049::aid-cncr1>3.0.co;2-2 · Cited by 2,115
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Epidemiologic Research: Principles and Quantitative Methods.
Pocock, S. J., Kleinbaum, D. G., Kupper, L. L., & Morgenstern, H. (1983) · Biometrics · doi:10.2307/2531133 · Cited by 1,893
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Govindarajulu, Z., Kendall, M., & Gibbons, J. D. (1992) · Technometrics · doi:10.2307/1269571 · Cited by 1,130
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
Petitti, D. B. (1999) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133646.001.0001 · Cited by 925
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Bias in treatment assignment in controlled clinical trials
Chalmers, T. C., Celano, P., Sacks, H. S., & Smith, H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092204 · Cited by 864
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
Pera, M., Cameron, A. J., Trastek, V. F., Carpenter, H. A., & Zinsmeister, A. R. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90420-h · Cited by 856
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
Sampliner, R. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00243-3 · Cited by 817
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
Shaheen, N. J., Crosby, M. A., Bozymski, E. M., & Sandler, R. S. (2000) · Gastroenterology · doi:10.1053/gast.2000.9302 · Cited by 758
Sulindac causes regression of rectal polyps in familial adenomatous polyposis
Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M., & Attali, P. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90519-q · Cited by 719
Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
Chow, W.-H., Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D., Stanford, J. L., Dubrow, R., Schoenberg, J. B., Mayne, S. T., Farrow, D. C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.150 · Cited by 626
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia
Gammon, M. D., Schoenberg, J. B., Ahsan, H., Risch, H. A., Vaughan, T. L., Chow, W. H., Rotterdam, H., West, A. B., Dubrow, R., Stanford, J. L., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1277 · Cited by 622
Schulz, K. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520020051014 · Cited by 512
Invited commentary: a critical look at some popular meta-analytic methods
Greenland, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117248 · Cited by 511
Non-Steroidal Anti-Inflammatory Drugs: Current Status and Rational Therapeutic Use
Hart, F. D., & Huskisson, E. C. (1984) · Drugs · doi:10.2165/00003495-198427030-00004 · Cited by 507
Nugent, K. P., Farmer, K. C. R., Spigelman, A. D., Williams, C. B., & Phillips, R. K. S. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800801244 · Cited by 490
The changing epidemiology of esophageal cancer.
Blot, W. J., & McLaughlin, J. K. (1999) · PubMed · Cited by 484
Shirvani, V. N., Ouatu-Lascar, R., Kaur, B. S., Omary, M. B., & Triadafilopoulos, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70254-x · Cited by 443
Langman, M. J. S. (2000) · BMJ · doi:10.1136/bmj.320.7250.1642 · Cited by 419
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Continuing Climb in Rates of Esophageal Adenocarcinoma: An Update
Blot, W. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510110056031 · Cited by 413
Molecular pathology of cyclooxygenase-2 in neoplasia.
Fosslien, E. (2000) · PubMed · Cited by 394
Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
Powell, J., & McConkey, C. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.314 · Cited by 381
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
Konstam, M. A., Weir, M. R., Reicin, A., Shapiro, D., Sperling, R. S., Barr, E., & Gertz, B. J. (2001) · Circulation · doi:10.1161/hc4401.100078 · Cited by 352
Random-Effects Meta-Analyses Are Not Always Conservative
Poole, C., & Greenland, S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010035 · Cited by 338
Aspirin and reduced risk of esophageal carcinoma
Funkhouser, E. M., & Sharp, G. B. (1995) · Cancer · doi:10.1002/1097-0142(19951001)76:7<1116::aid-cncr2820760703>3.0.co;2-i · Cited by 286
Non-steroidal anti-inflammatory drugs
Carbone, C., Musumeci, T., & Pignatello, R. (2013) · Drug-Biomembrane Interaction Studies · doi:10.1533/9781908818348.281 · Cited by 269
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., & Giardiello, F. M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90411-5 · Cited by 251
Cyclooxygenase-2 expression in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence
Morris, C. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02392-3 · Cited by 251
Gallo, O., Masini, E., Bianchi, B., Bruschini, L., Paglierani, M., & Franchi, A. (2002) · Human Pathology · doi:10.1053/hupa.2002.125376 · Cited by 214
Brown, L. M., Silverman, D. T., Pottern, L. M., Schoenberg, J. B., Greenberg, R. S., Swanson, G. M., Liff, J. M., Schwartz, A. G., Hayes, R. B., Blot, W. J., et al. (1994) · Cancer Causes & Control · doi:10.1007/bf01804984 · Cited by 202
A case-control study of oesophageal adenocarcinoma in women: a preventable disease
Cheng, K. K., Sharp, L., McKinney, P. A., Logan, R. F. A., Chilvers, C. E. D., Cook-Mozaffari, P., Ahmed, A., & Day, N. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1121 · Cited by 191
Incidence of cancer of the esophagus in the US by histologic type
Yang, P. C.-P., & Davis, S. (1988) · Cancer · Cited by 188
García Rodríguez, L. A., Varas, C., & Patrono, C. (2000) · Epidemiology · doi:10.1097/00001648-200007000-00004 · Cited by 177
Hansen, S., Wiig, J. N., Giercksky, K. E., & Tretli, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<340::aid-ijc5>3.0.co;2-y · Cited by 174
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden
Hansson, L., Sparén, P., & Nyrén, O. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540309 · Cited by 164
Coogan, P. F., Rosenberg, L. A., Palmer, J. R., Strom, B. L., Zauber, A. G., Stolley, P., & Shapiro, S. (2000) · PubMed · Cited by 146
Imperiale, T. F., & Birgisson, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-12-199712150-00002 · Cited by 143
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985
Hansson, L.-E., Sparén, P., & Nyrén, O. (1993) · British journal of surgery · doi:10.1002/bjs.1800800338 · Cited by 139
Taylor, P. R., Li, B., Dawsey, S. M., Li, J., Yang, C. S., Guo, W., & Blot, W. J. (1994) · PubMed · Cited by 112
Rising incidence of oesophageal adenocarcinoma in men in Australia
Lord, R. V., Law, M. G., Ward, R. L., Giles, G. G., Thomas, R. J. S., & Thursfield, V. J. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00646.x · Cited by 108
Garidou, A., Τζώνου, Α., Lipworth, L. P., Signorello, L. B., Kalapothaki, V., & Trichopoulos, D. (1996) · International Journal of Cancer · Cited by 94
Shureiqi, I., Xu, X., Chen, D., Lotan, R., Morris, J. S., Fischer, S. M., & Lippman, S. M. (2001) · PubMed · Cited by 91
Resolving conflicting clinical trials: Guidelines for meta-analysis
Gerbarg, Z. B., & Horwitz, R. I. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90053-4 · Cited by 90
Cancer-related behavior of vitamin supplement users.
Patterson, R. E., Neuhouser, M. L., White, E., Hunt, J. R., & Kristal, A. R. (1998) · PubMed · Cited by 88
Risk factors for squamous cell carcinoma of the oesophagus in women: a case–control study
Sharp, L. A., Chilvers, C. E. D., Cheng, K. K., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2147 · Cited by 84
Oesophageal and gastric cancer in Scotland 1960-90
McKinney, P. A., Sharp, L., Macfarlane, G. J., & Cs, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.84 · Cited by 83
H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma
Suleiman, U., Harrison, M., Britton, A. R., McPherson, K., & Bates, T. (2000) · European Journal of Cancer Prevention · doi:10.1097/00008469-200006000-00006 · Cited by 79
Chang-Claude, J. C., Wahrendorf, J., Liang, Q. S., Rei, Y. G., Muñoz, N., Crespi, M., Raedsch, R., Thurnham, D. I., & Corréa, P. (1990) · PubMed · Cited by 76
INCIDENCE TRENDS IN OESOPHAGEAL AND PROXIMAL GASTRIC CARCINOMA IN VICTORIA
Thomas, R. J. S., Lade, S., Giles, G. G., & Thursfield, V. J. (1996) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1996.tb01183.x · Cited by 65
Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs
Shaheen, N. J., Straus, W. L., & Sandler, R. S. (2002) · Cancer · doi:10.1002/cncr.10333 · Cited by 63
Heath, C. W., Thun, M. J., Greenberg, E. R., Levin, B., & Marnett, L. J. (1994) · Cancer · doi:10.1002/1097-0142(19941115)74:10<2885::aid-cncr2820741023>3.0.co;2-p · Cited by 63
Jick, S. S. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.9.741.35209 · Cited by 42
Imperiale, T. F. (1999) · PubMed · Cited by 31
Non-steroidal anti-inflammatory drugs
Day, R. O. (2019) · Reactions Weekly · doi:10.1007/s40278-019-59590-0 · Cited by 8
Cited by
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
Shaheen, N. J., Falk, G. W., Iyer, P. G., & Gerson, L. B. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.322 · Cited by 1,501
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 1,060
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study
Ronkainen, J., Aro, P., Storskrubb, T., Johansson, S., Lind, T., Bolling–Sternevald, E., Vieth, M., Stolte, M., Talley, N. J., & Agréus, L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.053 · Cited by 940
Metadata
- Authors
- Corley, D. A., Kerlikowske, K., Verma, R., & Buffler, P.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 124
- Issue
- 1
- Pages
- 47-56
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1993228606
- Cited by
- 527
- References
- 71
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.